81 Comparing FVIII concentration and activity 17. Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, Ludlam CA, Mahlangu JN, Mulder K, Poon MC, Street A, Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia. Guidelines for the management of hemophilia. Haemophilia. 2013; 19: e1-47. 18. ten Berg MJ, Huisman A, van den Bemt PM, Schobben AF, Egberts AC, van Solinge WW. Linking laboratory and medication data: new opportunities for pharmacoepidemiological research. Clin Chem Lab Med. 2007; 45: 13-19. 19. Amano K, Sarkar R, Pemberton S, Kemball-Cook G, Kazazian HH, Jr., Kaufman RJ. The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIII. Blood. 1998; 91: 538-548. 20. van Moort I, Meijer P, Priem-Visser D, van Gammeren AJ, Pequeriaux NCV, Leebeek FWG, Cnossen MH, de Maat MPM. Analytical variation in factor VIII one-stage and chromogenic assays: Experiences from the ECAT external quality assessment programme. Haemophilia. 2019; 25: 162-169. 21. Trossaert M, Boisseau P, Quemener A, Sigaud M, Fouassier M, Ternisien C, Lefrancois-Bettembourg A, Tesson C, Thomas C, Bezieau S. Prevalence, biological phenotype and genotype in moderate/mild hemophilia A with discrepancy between one-stage and chromogenic factor VIII activity. J Thromb Haemost. 2011; 9: 524-530. 22. Kessler CM. An introduction to factor VIII inhibitors: the detection and quantitation. Am J Med. 1991; 91: 1S-5S. 23. Batsuli G, Ito J, Mercer R, Baldwin WH, Cox C, Parker ET, Healey JF, Lollar P, Meeks SL. Anti-C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model. J Thromb Haemost. 2018; 16: 1779-1788. 24. Barrowcliffe TW, Raut S, Sands D, Hubbard AR. Coagulation and chromogenic assays of factor VIII activity: general aspects, standardization, and recommendations. Semin Thromb Hemost. 2002; 28: 247-256. 25. Mohammed Y, van Vlijmen BJ, Yang J, Percy AJ, Palmblad M, Borchers CH, Rosendaal FR. Multiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancer. Blood Adv. 2017;1(15):1080-1087. 4
RkJQdWJsaXNoZXIy MTk4NDMw